OISVX
Price
$14.70
Change
+$0.22 (+1.52%)
Updated
Dec 3 closing price
Net Assets
600.31M
VISVX
Price
$50.89
Change
+$0.54 (+1.07%)
Updated
Dec 3 closing price
Net Assets
58.35B
Interact to see
Advertisement

OISVX vs VISVX

Header iconOISVX vs VISVX Comparison
Open Charts OISVX vs VISVXBanner chart's image
Optimum Small-Mid Cap Value Instl
Price$14.70
Change+$0.22 (+1.52%)
VolumeN/A
Net Assets600.31M
Vanguard Small Cap Value Index I
Price$50.89
Change+$0.54 (+1.07%)
VolumeN/A
Net Assets58.35B
OISVX vs VISVX Comparison Chart in %
View a ticker or compare two or three
VS
OISVX vs. VISVX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OISVX is a Buy and VISVX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VISVX has more cash in the bank: 58.3B vs. OISVX (600M). VISVX pays higher dividends than OISVX: VISVX (1.86) vs OISVX (0.94). OISVX was incepted earlier than VISVX: OISVX (22 years) vs VISVX (28 years). OISVX (1.33) is less costly to investors than VISVX (0.19). OISVX is a more actively managed with annual turnover of: 117.00 vs. VISVX (16.00). OISVX has a lower initial minimum investment than VISVX: OISVX (0) vs VISVX (3000). VISVX annual gain was more profitable for investors over the last year : -0.42 vs. OISVX (-11.02). VISVX return over 5 years is better than : 54.12 vs. OISVX (11.50).
OISVXVISVXOISVX / VISVX
Total Expense Ratio1.240.19653%
Annual Report Gross Expense Ratio1.330.19700%
Fund Existence22 years28 years-
Gain YTD2.3687.43932%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets600M58.3B1%
Annual Yield % from dividends0.941.8651%
Returns for 1 year-11.02-0.422,625%
Returns for 3 years1.1027.284%
Returns for 5 years11.5054.1221%
Returns for 10 years20.38114.1618%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
MVV70.010.98
+1.42%
ProShares Ultra MidCap400
FTXH32.750.38
+1.18%
First Trust Nasdaq Pharmaceuticals ETF
RPAR21.630.16
+0.75%
RPAR Risk Parity ETF
CGCP22.750.05
+0.22%
Capital Group Core Plus Income ETF
CPRJ26.670.05
+0.20%
Calamos Russell 2000 Str Alt Prt ETF-Jul